| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines
|
Parreiras, P.M.
|
|
2009
|
27 |
33 |
p. 4537-4542
6 p.
|
artikel
|
| 2 |
Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge
|
Platt, Ratree
|
|
2009
|
27 |
33 |
p. 4508-4519
12 p.
|
artikel
|
| 3 |
Cost-effectiveness of infant vaccination with RIX4414 (Rotarix™) in the UK
|
Martin, A.
|
|
2009
|
27 |
33 |
p. 4520-4528
9 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2009
|
27 |
33 |
p. CO2-
1 p.
|
artikel
|
| 5 |
Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: A case–control study
|
Joshi, Avni Y.
|
|
2009
|
27 |
33 |
p. 4457-4461
5 p.
|
artikel
|
| 6 |
Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
|
Herzog, Christian
|
|
2009
|
27 |
33 |
p. 4381-4387
7 p.
|
artikel
|
| 7 |
Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation
|
Pannaraj, Pia S.
|
|
2009
|
27 |
33 |
p. 4452-4456
5 p.
|
artikel
|
| 8 |
Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen
|
Hodge, James W.
|
|
2009
|
27 |
33 |
p. 4475-4482
8 p.
|
artikel
|
| 9 |
Improved immunization practices reduce childhood hepatitis B infection in Tonga
|
Danielsson, Niklas
|
|
2009
|
27 |
33 |
p. 4462-4467
6 p.
|
artikel
|
| 10 |
Investigation of serum bactericidal activity in childhood and adolescence 3–6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine
|
Sakou, Irine-Ikbale
|
|
2009
|
27 |
33 |
p. 4408-4411
4 p.
|
artikel
|
| 11 |
ISCOMs and ISCOMATRIX™
|
Sun, Hong-Xiang
|
|
2009
|
27 |
33 |
p. 4388-4401
14 p.
|
artikel
|
| 12 |
MPT-51/CpG DNA vaccine protects mice against Mycobacterium tuberculosis
|
Silva, Bruna Daniella de Souza
|
|
2009
|
27 |
33 |
p. 4402-4407
6 p.
|
artikel
|
| 13 |
Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis
|
Troyer, Ryan M.
|
|
2009
|
27 |
33 |
p. 4424-4433
10 p.
|
artikel
|
| 14 |
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis
|
Sun, Ronggai
|
|
2009
|
27 |
33 |
p. 4412-4423
12 p.
|
artikel
|
| 15 |
Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector
|
Ogawa, Yohsuke
|
|
2009
|
27 |
33 |
p. 4543-4550
8 p.
|
artikel
|
| 16 |
Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methods
|
Lundgren, Anna
|
|
2009
|
27 |
33 |
p. 4529-4536
8 p.
|
artikel
|
| 17 |
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice
|
Voltan, Rebecca
|
|
2009
|
27 |
33 |
p. 4498-4507
10 p.
|
artikel
|
| 18 |
Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3
|
Webb, Robert P.
|
|
2009
|
27 |
33 |
p. 4490-4497
8 p.
|
artikel
|
| 19 |
Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders
|
Sarkar-Tyson, Mitali
|
|
2009
|
27 |
33 |
p. 4447-4451
5 p.
|
artikel
|
| 20 |
Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus
|
Guthrie, Alan J.
|
|
2009
|
27 |
33 |
p. 4434-4438
5 p.
|
artikel
|
| 21 |
Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity
|
Gudmundsdotter, Lindvi
|
|
2009
|
27 |
33 |
p. 4468-4474
7 p.
|
artikel
|
| 22 |
Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study
|
Kaltenböck, A.
|
|
2009
|
27 |
33 |
p. 4483-4489
7 p.
|
artikel
|
| 23 |
Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants
|
Poot, J.
|
|
2009
|
27 |
33 |
p. 4439-4446
8 p.
|
artikel
|
Tijdschrift beschrijving